14 source-based articles maintained by the HealthRX.com Editorial Team.
Showing 14 of 14 clinical reviews.
Alpha-lipoic acid and CJC-1295 (modified GRF 1-29) share overlapping effects on blood glucose and thyroid hormone metabolism. Learn the pharmacodynamic interaction, dose-separation strategy, and monitoring plan.
A guide covering the pharmacodynamic interactions between ashwagandha (KSM-66 / Sensoril) and CJC-1295 modified GRF, including cortisol modulation, GH axis effects, thyroid impact, and practical dosing guidance.
A guide covering the pharmacokinetics, pharmacodynamics, safety profile, and clinical monitoring recommendations for combining CoQ10 with CJC-1295 modified GRF.
Evidence-based guide on combining creatine supplementation with CJC-1295 (modified GRF 1-29). Covers the creatinine elevation concern, renal monitoring protocols, dose-separation windows, and clinical safety data.
A clinical review of the pharmacodynamic and pharmacokinetic interactions between ginseng and CJC-1295 modified GRF, including glucose effects, anticoagulant potentiation, monitoring parameters, and dosing guidance from a board-certified medical team.
A guide to combining glycine with CJC-1295 modified GRF: mechanism, pharmacodynamic interactions, dosing windows, glycemic monitoring, and safety evidence.
Evidence-based guide on combining green tea extract (EGCG) with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interaction concerns, hepatotoxicity risk, dose-separation strategies, and monitoring recommendations.
A guide to the CJC-1295 and magnesium interaction: mechanisms, safety, dosing timing, monitoring, and clinical recommendations for patients on GH secretagogue therapy.
Evidence-based guide to combining melatonin with CJC-1295 modified GRF. Covers pharmacokinetic and pharmacodynamic interaction mechanisms, dose-separation windows, glucose monitoring, and clinical recommendations.
Evidence-based guide on combining NAC with CJC-1295 modified GRF. Covers interaction mechanisms, dose-separation windows, monitoring, and safety considerations.
A clinically reviewed guide to combining omega-3 (EPA/DHA) with CJC-1295 modified GRF, covering pharmacodynamic interactions, antiplatelet concerns, triglyceride monitoring, and practical dosing guidance.
St. John's Wort is a potent CYP3A4 inducer that may alter CJC-1295 metabolism. Learn the pharmacokinetic interaction, dose-separation strategies, monitoring recommendations, and what to do if you already take both.
A guide to the pharmacokinetic and pharmacodynamic interactions between CJC-1295 (modified GRF) and turmeric / curcumin, including dosing windows, monitoring, and safety evidence.
Evidence-based guide on combining vitamin B12 supplementation with CJC-1295 modified GRF, covering interaction risk, dose timing, monitoring, and clinical considerations.